Non-Myeloablative Stem Cell Transplantation in Hematologic Malig¬nancies: An Experience from the Hematology-Oncology and BMT Re¬search Center

Background: Myeloablative-allogeneic stem cell transplantation is a common way of treating various malignant and nonma-lignant diseases; but, it is associated with hazardous immediate and late complications. The majority of patients are not good candidates for high dose therapy because of old age,...

Full description

Bibliographic Details
Main Authors: S Keyhanian, A Ghavamzadeh, B Bahar, K Alimoghaddam, AR Shamshiri, S Gholibeikian
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2004-03-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/170